| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride Dihydrate |
| Available forms, composition and doses of Ondansetron-RL: |
| Injectable; Injection; Ondansetron Hydrochloride Dihydrate 2 mg / mlTablets; Oral; Ondansetron Hydrochloride Dihydrate 4 mgTablets; Oral; Ondansetron Hydrochloride Dihydrate 8 mg |
| Ondansetron-RL medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |